PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Dementia

CMS initiates official review of PET scan limit for patients with Alzheimer's

"Clinical study protocols may involve more than one PET [amyloid-beta] scan per patient,” the CMS announcement said.

June 28, 2022
lung cancer pulmonary nodule chest

Preoperative PET/CT imaging linked with better survival in advanced lung cancer

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam. 

June 24, 2022
U.S. News & World Report children’s hospitals cardiology heart surgery

Lower doses, faster acquisitions: Experts share how to improve PET scans for peds

This week in AJR, experts shared how they were able to reduce FDG PET scan acquisition times by 33%, thus reducing the amount of total radiation exposure to more vulnerable pediatric patients. 

June 22, 2022
SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

‘Image of the Year’ highlights the predictive power of a new PET imaging agent

The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

June 15, 2022
prostate cancer recurrence on PET outside of SRT guidelines

PSMA PET mapping improves radiation therapy contouring after PCA recurrence

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

June 14, 2022

Cutting radiation exposure in half during PET/CT using virtual CT scans

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

June 13, 2022
right.jpg

PET/CT contrast debate: ‘Time to unleash the full power’ vs. ‘More is not always better’

Hybrid PET/CT enhanced with intravenous CT contrast deserves wider acceptance and adoption, as diagnostically optimized CT can complement PET—and vice versa—for a variety of potential indications. That’s one opinion on the matter.

May 26, 2022

New radiohybrid PET imaging agent increases detection of prostate cancer recurrence

For 45% to 47% of patients who were deemed negative after conventional baseline scans, the use of the radiohybrid imaging agent resulted in at least one true positive PET finding

May 16, 2022